Review
doi: 10.1038/nri2233.
Creating immune privilege: active local suppression that benefits friends, but protects foes
Affiliations
- PMID: 18064049
- DOI: 10.1038/nri2233
Item in Clipboard
Review
Creating immune privilege: active local suppression that benefits friends, but protects foes
Nat Rev Immunol.
2008 Jan.
Erratum in
- Nat Rev Immunol. 2008 Feb;8(2):160
Abstract
Natural regulatory mechanisms prevent inappropriate immune activation to self and innocuous foreign antigens. Here, we adapt the notion of immune privilege, which was originally applied to transplanted tissues, to consider how antigenic tumour cells and chronic pathogens might exploit natural regulatory mechanisms to become non-immunogenic. This conceptual approach reveals new mechanistic perspectives that may help to explain the paradoxical persistence of tumours and chronic pathogens, and suggests new opportunities to improve immunotherapy to treat these chronic inflammatory diseases.
Similar articles
-
TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.Oncogene. 2008 Jan 7;27(2):168-80. doi: 10.1038/sj.onc.1210910. Oncogene. 2008. PMID: 18176598 Review.
-
Is the liver an important site for the development of immune tolerance to tumours?Med Hypotheses. 2005;64(4):751-4. doi: 10.1016/j.mehy.2004.10.002. Med Hypotheses. 2005. PMID: 15694692
-
Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.Immunol Rev. 2008 Aug;224:141-65. doi: 10.1111/j.1600-065X.2008.00649.x. Immunol Rev. 2008. PMID: 18759925 Review.
-
How the immune system achieves self-nonself discrimination during adaptive immunity.Adv Immunol. 2009;102:95-133. doi: 10.1016/S0065-2776(09)01202-4. Adv Immunol. 2009. PMID: 19477320 Review.
-
[Immune tolerance and control of CNS autoimmunity: from animal models to MS patients].Rev Neurol (Paris). 2007 Sep;163 Spec No 1:3S12-22. Rev Neurol (Paris). 2007. PMID: 18087225 Review. French.
Cited by
-
The role of indoleamine 2, 3 dioxygenase in regulating host immunity to leishmania infection.J Biomed Sci. 2012 Jan 9;19(1):5. doi: 10.1186/1423-0127-19-5. J Biomed Sci. 2012. PMID: 22230608 Free PMC article.
-
Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer.J Transl Med. 2013 Jun 13;11:147. doi: 10.1186/1479-5876-11-147. J Transl Med. 2013. PMID: 23763830 Free PMC article. Review.
-
Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps.Pharmacol Ther. 2016 Oct;166:30-9. doi: 10.1016/j.pharmthera.2016.06.010. Epub 2016 Jun 29. Pharmacol Ther. 2016. PMID: 27373504 Free PMC article. Review.
-
The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy.Int J Tryptophan Res. 2016 Oct 12;9:67-77. doi: 10.4137/IJTR.S38355. eCollection 2016. Int J Tryptophan Res. 2016. PMID: 27773992 Free PMC article. Review.
-
M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection.PLoS One. 2012;7(5):e37314. doi: 10.1371/journal.pone.0037314. Epub 2012 May 23. PLoS One. 2012. PMID: 22649518 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
